Ari Maizel insider trades
Open-market stock purchases and sales by Ari Maizel, Chief Commercial Officer at Axsome Therapeutics, Inc, from SEC Form 4 filings since Feb 21, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 22, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $1.4M |
| Apr 22, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Jan 21, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $1.4M |
| Jan 21, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- AXSM Axsome Therapeutics, Inc: 2 sales, last Apr 22, 2026